The US Food and Drug Administration’s faster turnaround of facility classification decisions is providing greater transparency for drug sponsors into the inspectional status of their contract manufacturers, Center for Drug Evaluation and Research compliance office director Donald Ashley said.
In fiscal year 2019, CDER notified the facility owner of its classification status within 90 days after an inspection 86%...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?